Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms.
Despite the reduced incidence of gastric cancer in the developed world, a diagnosis of stomach carcinoma still carries a poor prognosis due to the asymptomatic nature of the disease in the early stages, subsequent advanced stage diagnosis, and a low 5 year survival rate. Endoscopy remains the primar...
Main Authors: | Bones, J, Byrne, J, O'Donoghue, N, McManus, C, Scaife, C, Boissin, H, Nastase, A, Rudd, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Toward spatial glycomics and glycoproteomics: Innovations and applications
by: Patcharaporn Boottanun, et al.
Published: (2025-01-01) -
Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers
by: Firas Kobeissy, et al.
Published: (2022-02-01) -
Recent Advances in Mass Spectrometry-Based Glycomic and Glycoproteomic Studies of Pancreatic Diseases
by: Dylan Nicholas Tabang, et al.
Published: (2021-07-01) -
Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma
by: Zhuo Li, et al.
Published: (2024-04-01) -
An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors
by: Michael Russelle S. Alvarez, et al.
Published: (2022-06-01)